Xiaoying Wang (Wang Xiaoying)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Cognitive Decline

Lipopolysaccharide Induced

Signaling Pathway

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Oxidative medicine and cellular longevity

British journal of pharmacology

Neurochemical research

This page only lists publications with an associated author ORCID identifier.

Publications

Bin Lv, Jinhe Guo, Yaodong Du, Yang Chen, Xin Zhao, Bin Yu, Jiarui Liu, Tianyi Cui, Haoping Mao, Xiaoying Wang, Xiumei Gao
Chlorogenic acid reduces inflammation by inhibiting the elevated expression of KAT2A to ameliorate lipopolysaccharide-induced acute lung injury. British journal of pharmacology (2023)
Xiao Liu, Kaiyue Wang, Xing Wei, Tian Xie, Bin Lv, Qian Zhou, Xiaoying Wang
Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments. Neurochemical research 46 (4) (2021)
Wangxiao Tan, Yu Wang, Kaiyue Wang, Siwei Wang, Jinghua Liu, Xiaoyan Qin, Yongna Dai, Xiaoying Wang, Xiu-Mei Gao
Improvement of Endothelial Dysfunction of Berberine in Atherosclerotic Mice and Mechanism Exploring through TMT-Based Proteomics. Oxidative medicine and cellular longevity 2020 (2020)
Zhaojian Zhang, Yu Wang, Wangxiao Tan, Siwei Wang, Jinghua Liu, Xiao Liu, Xiaoying Wang, Xiu-Mei Gao
A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)
Yang Yang, Wang Ting, Xiao Liu, Fu Shufei, Wangxiao Tan, Xiaoying Wang, Gao Xiumei, Zhang Boli
Immunoregulation of Shenqi Fuzheng Injection Combined with Chemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM 2017 (2017)